OK Cannabis: $60M Revenue Loss Signals Market Shift

OK Cannabis: $60M Revenue Loss Signals Market Shift

James Chen

Written by

James Chen

Oklahoma’s Cannabis Moratorium: A $60 Million Question of Market Correction

$60 million. That’s the estimated revenue loss to Oklahoma’s state government in 2023 alone, directly attributable to the oversupply and subsequent price collapse within the medical marijuana market. While lawmakers debate extending the current moratorium on new business licenses – and potentially capping grower licenses – the core issue isn’t simply regulatory catch-up, but a fundamental miscalculation of market demand. Two bills, HB 3143 and HB 3144, authored by Representative Rusty Cornwell, R-Vinita, represent an attempt to stabilize a market reeling from its own success, but the proposed solutions reveal a striking reluctance to define what “stable” actually looks like.

See the original news9.com story for the full account.

The current moratorium, first enacted in 2022, was a reactive measure to a surge in licensing. As Cornwell himself admits, the market “just got out of hand rather quickly.” In 2021 and early 2022, Oklahoma saw an explosion of cannabis businesses, peaking at over 10,000 licenses. This rapid expansion, fueled by comparatively lax regulations, led to a glut of product, driving down wholesale prices and crippling many operators. The state’s initial optimism – projecting significant tax revenue – quickly evaporated. Tax revenue from medical marijuana peaked at $86.7 million in April 2022, according to the Oklahoma Tax Commission, and has since fallen by over 30%, a direct consequence of the price compression. HB 3143 proposes extending the moratorium to 2028, essentially hitting the pause button on new entrants while the existing market attempts to absorb the oversupply.

However, the more revealing piece of legislation is HB 3144, which proposes a cap of 2,550 grow licenses once the moratorium is lifted. This figure, a modest increase from the current 2,164, is particularly telling. Cornwell acknowledges that some stakeholders believe as few as 60-120 facilities could adequately serve Oklahoma’s medical marijuana patients, yet he deliberately chose a higher number, stating he “didn’t want to try find what the real number was.” This reluctance to conduct a thorough market analysis – to determine actual demand versus existing capacity – suggests a political calculation prioritizing the interests of existing license holders over a truly efficient market. The proposed cap isn’t about optimizing supply; it’s about managing the fallout from past over-licensing while appeasing a vocal constituency.

The industry itself is largely supportive, albeit cautiously. Brandy Keenan, owner of OK Canna Consulting, frames the bills as a necessary breathing space for regulatory bodies to “catch up,” and for existing businesses to achieve profitability. This perspective highlights a key tension: the initial rush to market outpaced the state’s ability to effectively regulate and oversee the industry. However, Keenan’s emphasis on profitability for existing businesses underscores the inherent conflict of interest in shaping policy around a limited number of licenses. Jed Green, of Oklahomans for Responsible Cannabis Action, echoes this sentiment, calling the bills “reasonable policy proposals” and praising lawmakers for a “proactive approach.” This broad support from advocacy groups suggests a consensus that some form of intervention is necessary, even if the proposed solutions are imperfect.

The bills have passed the House with bipartisan support and are now before the Senate. The passage of these bills isn’t simply a regulatory adjustment; it’s a tacit admission of a failed market experiment. Oklahoma attempted to capitalize on the burgeoning cannabis industry with minimal barriers to entry, and the result was predictable: oversupply, price collapse, and significant revenue losses. The question now isn’t whether the moratorium should be extended, but whether Oklahoma will learn from its mistakes and invest in data-driven market analysis before the next legislative review in 2028. What this means for your wallet: expect continued high prices for medical marijuana in the short term, driven by artificial scarcity. But more importantly, watch whether the Oklahoma Medical Marijuana Authority uses the extended moratorium to develop a comprehensive demand model – or simply prepares for another round of politically-motivated license caps.

Earlier on this story

Our prior reporting on the people, places, and policies in this piece.

Share:
James Chen

About the Author

James Chen

James Chen — Editor-in-Chief at OwlyTimes, which he founded in 2025 with a small team of editors. Reports on markets with a CPA's suspicion and a reporter's notebook. Came to the project after seven years on a regional business desk in Chicago, where he learned to read footnotes before press releases. Numbers tell stories; he edits the stories so they tell the truth.

This article is based on reporting from the original source. OwlyTimes editors verified facts and added independent context.

Related Articles